Therapeutic landscape in mutational triple negative breast cancer

被引：70

作者：

Shi, Yaqin ^{[1
]}

Jin, Juan ^{[1
]}

Ji, Wenfei ^{[2
]}

Guan, Xiaoxiang ^{[1
,2
,3
]}

机构：

[1] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210002, Jiangsu, Peoples R China

[2] Nanjing Med Univ, Dept Med Oncol, Jinling Clin Coll, Nanjing 210002, Jiangsu, Peoples R China

[3] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing 210029, Jiangsu, Peoples R China

来源：

MOLECULAR CANCER | 2018年 / 17卷

基金：

中国国家自然科学基金;

关键词：

Somatic; Germline; Mutation; Therapeutic; TNBC; GROWTH-FACTOR RECEPTOR; PATHOLOGICAL COMPLETE RESPONSE; BRCA2 GERMLINE MUTATIONS; NEOADJUVANT CHEMOTHERAPY; SUSCEPTIBILITY GENES; 1ST-LINE TREATMENT; PROSPECTIVE COHORT; DOUBLE-BLIND; WOMEN; COMBINATION;

D O I：

10.1186/s12943-018-0850-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Triple negative breast cancer (TNBC) is a heterogeneous disease with aggressive behavior and poor prognosis. Genomic sequencing has detected a distinctive mutational portrait of both the germline and somatic alterations in TNBC, which is staggeringly different from other breast cancer subtypes. The clinical utility of sequencing germline BRCA1/2 genes has been well established in TNBC. However, for other predisposition genes, studies concerning the risk and penetrance to TNBC are relatively scarce. Very few recurrent mutations, including TP53 and PI3KCA mutations, together with a long tail of individually rare mutations occur in TNBC. These combined effects of genomic alterations drive TNBC progression. Given the complexity and heterogeneity of TNBC, clinical interpretation of the genomic alterations in TNBC may pave a new way for the treatment of TNBC. In this review, we summarized the germline and somatic mutation profiles of TNBC and discussed the current and upcoming therapeutic strategies targeting the mutant proteins or pathways to enable tailored-therapeutics.

引用

页数：11

共 89 条

[1] Distribution of Molecular Breast Cancer Subtypes in Middle Eastern-Saudi Arabian Women: A Pilot Study [J].

Al-Tamimi, Dalal M. ;

Bernard, Philip S. ;

Shawarby, Mohamed A. ;

Al-Amri, Ali M. ;

Hadi, Maha Abdel .

ULTRASTRUCTURAL PATHOLOGY, 2009, 33 (04) :141-150

[2] Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial [J].

Andre, Fabrice ;

O'Regan, Ruth ;

Ozguroglu, Mustafa ;

Toi, Masakazu ;

Xu, Binghe ;

Jerusalem, Guy ;

Masuda, Norikazu ;

Wilks, Sharon ;

Arena, Francis ;

Isaacs, Claudine ;

Yap, Yoon-Sim ;

Papai, Zsuzsanna ;

Lang, Istvan ;

Armstrong, Anne ;

Lerzo, Guillermo ;

White, Michelle ;

Shen, Kunwei ;

Litton, Jennifer ;

Chen, David ;

Zhang, Yufen ;

Ali, Shyanne ;

Taran, Tetiana ;

Gianni, Luca .

LANCET ONCOLOGY, 2014, 15 (06) :580-591

[3] Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer [J].

Atchley, Deann P. ;

Albarracin, Constance T. ;

Lopez, Adriana ;

Valero, Vicente ;

Amos, Christopher I. ;

Gonzalez-Angulo, Ana Maria ;

Hortobagyi, Gabriel N. ;

Arun, Banu K. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) :4282-4288

[4] Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer [J].

Balko, Justin M. ;

Schwarz, Luis J. ;

Bhola, Neil E. ;

Kurupi, Richard ;

Owens, Phillip ;

Miller, Todd W. ;

Gomez, Henry ;

Cook, Rebecca S. ;

Arteaga, Carlos L. .

CANCER RESEARCH, 2013, 73 (20) :6346-6358

[5] Sequence analysis of mutations and translocations across breast cancer subtypes [J].

Banerji, Shantanu ;

Cibulskis, Kristian ;

Rangel-Escareno, Claudia ;

Brown, Kristin K. ;

Carter, Scott L. ;

Frederick, Abbie M. ;

Lawrence, Michael S. ;

Sivachenko, Andrey Y. ;

Sougnez, Carrie ;

Zou, Lihua ;

Cortes, Maria L. ;

Fernandez-Lopez, Juan C. ;

Peng, Shouyong ;

Ardlie, Kristin G. ;

Auclair, Daniel ;

Bautista-Pina, Veronica ;

Duke, Fujiko ;

Francis, Joshua ;

Jung, Joonil ;

Maffuz-Aziz, Antonio ;

Onofrio, Robert C. ;

Parkin, Melissa ;

Pho, Nam H. ;

Quintanar-Jurado, Valeria ;

Ramos, Alex H. ;

Rebollar-Vega, Rosa ;

Rodriguez-Cuevas, Sergio ;

Romero-Cordoba, Sandra L. ;

Schumacher, Steven E. ;

Stransky, Nicolas ;

Thompson, Kristin M. ;

Uribe-Figueroa, Laura ;

Baselga, Jose ;

Beroukhim, Rameen ;

Polyak, Kornelia ;

Sgroi, Dennis C. ;

Richardson, Andrea L. ;

Jimenez-Sanchez, Gerardo ;

Lander, Eric S. ;

Gabriel, Stacey B. ;

Garraway, Levi A. ;

Golub, Todd R. ;

Melendez-Zajgla, Jorge ;

Toker, Alex ;

Getz, Gad ;

Hidalgo-Miranda, Alfredo ;

Meyerson, Matthew .

NATURE, 2012, 486 (7403) :405-409

[6] Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and Bevacizumab [J].

Basho, Reva K. ;

Gilcrease, Michael ;

Murthy, Rashmi K. ;

Helgason, Thorunn ;

Karp, Daniel D. ;

Meric-Bernstam, Funda ;

Hess, Kenneth R. ;

Herbrich, Shelley M. ;

Valero, Vicente ;

Albarracin, Constance ;

Litton, Jennifer K. ;

Chavez-MacGregor, Mariana ;

Ibrahim, Nuhad K. ;

Murray, James L., III ;

Koenig, Kimberly B. ;

Hong, David ;

Subbiah, Vivek ;

Kurzrock, Razelle ;

Janku, Filip ;

Moulder, Stacy L. .

JAMA ONCOLOGY, 2017, 3 (04) :509-515

[7] The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance [J].

Bouwman, Peter ;

Jonkers, Jos .

NATURE REVIEWS CANCER, 2012, 12 (09) :587-598

[8] Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China [J].

Cao, Wen-Ming ;

Gao, Yun ;

Wang, Xiao-Jia .

BREAST CANCER RESEARCH, 2015, 17

[9] Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women [J].

Comen, E. ;

Davids, M. ;

Kirchhoff, T. ;

Hudis, C. ;

Offit, K. ;

Robson, M. .

BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (01) :185-190

[10] Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer [J].

Couch, Fergus J. ;

Hart, Steven N. ;

Sharma, Priyanka ;

Toland, Amanda Ewart ;

Wang, Xianshu ;

Miron, Penelope ;

Olson, Janet E. ;

Godwin, Andrew K. ;

Pankratz, V. Shane ;

Olswold, Curtis ;

Slettedahl, Seth ;

Hallberg, Emily ;

Guidugli, Lucia ;

Davila, Jaime I. ;

Beckmann, Matthias W. ;

Janni, Wolfgang ;

Rack, Brigitte ;

Ekici, Arif B. ;

Slamon, Dennis J. ;

Konstantopoulou, Irene ;

Fostira, Florentia ;

Vratimos, Athanassios ;

Fountzilas, George ;

Pelttari, Liisa M. ;

Tapper, William J. ;

Durcan, Lorraine ;

Cross, Simon S. ;

Pilarski, Robert ;

Shapiro, Charles L. ;

Klemp, Jennifer ;

Yao, Song ;

Garber, Judy ;

Cox, Angela ;

Brauch, Hiltrud ;

Ambrosone, Christine ;

Nevanlinna, Heli ;

Yannoukakos, Drakoulis ;

Slager, Susan L. ;

Vachon, Celine M. ;

Eccles, Diana M. ;

Fasching, Peter A. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (04) :304-U154

← 1 2 3 4 5 6 7 8 9 →